1-4 of 4
Elisabeth Buchdunger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy

G. Sakuntala Warshamana-Greene, Julie Litz, Elisabeth Buchdunger, Carlos García-Echeverría, Francesco Hofmann, Geoffrey W. Krystal
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1563–1571.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-1544
Published: 02 March 2005
View article
PDF
Journal Articles

STI571 Enhances the Therapeutic Index of Epothilone B by a Tumor-selective Increase of Drug Uptake

Kristian Pietras, Michael Stumm, Martine Hubert, Elisabeth Buchdunger, Kristofer Rubin, Carl-Henrik Heldin, Paul McSheehy, Markus Wartmann, Arne Östman
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3779–3787.
Published: 23 September 2003
View article
PDF
Journal Articles

Optimization for the Blockade of Epidermal Growth Factor Receptor Signaling for Therapy of Human Pancreatic Carcinoma

Carmen C. Solorzano, Cheryl H. Baker, Rachel Tsan, Peter Traxler, Pamela Cohen, Elisabeth Buchdunger, Jerry J. Killion, Isaiah J. Fidler
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2563–2572.
Published: 01 August 2001
View article
PDF
Journal Articles

The Selective Tyrosine Kinase Inhibitor STI571 Inhibits Small Cell Lung Cancer Growth

Geoffrey W. Krystal, Sittisak Honsawek, Julie Litz, Elisabeth Buchdunger
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (8): 3319–3326.
Published: 01 August 2000
View article
PDF